These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26459237)

  • 1. DOX: A new computational protocol for accurate prediction of the protein-ligand binding structures.
    Rao L; Chi B; Ren Y; Li Y; Xu X; Wan J
    J Comput Chem; 2016 Jan; 37(3):336-44. PubMed ID: 26459237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Sarver RW; Bills E; Bolton G; Bratton LD; Caspers NL; Dunbar JB; Harris MS; Hutchings RH; Kennedy RM; Larsen SD; Pavlovsky A; Pfefferkorn JA; Bainbridge G
    J Med Chem; 2008 Jul; 51(13):3804-13. PubMed ID: 18540668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Istvan ES
    Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
    J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
    Islam B; Sharma C; Adem A; Aburawi E; Ojha S
    Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
    Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
    PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation Search Across Multiple-Level Potential-Energy Surfaces (CSAMP): A Strategy for Accurate Prediction of Protein-Ligand Binding Structures.
    Wei L; Chi B; Ren Y; Rao L; Wu J; Shang H; Liu J; Xiao Y; Ma M; Xu X; Wan J
    J Chem Theory Comput; 2019 Jul; 15(7):4264-4279. PubMed ID: 31142115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations.
    da Costa RF; Freire VN; Bezerra EM; Cavada BS; Caetano EW; de Lima Filho JL; Albuquerque EL
    Phys Chem Chem Phys; 2012 Jan; 14(4):1389-98. PubMed ID: 22159045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
    Brylinski M
    J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
    Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J
    Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.
    Lin SH; Huang KJ; Weng CF; Shiuan D
    Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).
    Thilagavathi R; Kumar R; Aparna V; Sobhia ME; Gopalakrishnan B; Chakraborti AK
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1027-32. PubMed ID: 15686906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge-guided docking: accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock.
    Cleves AE; Jain AN
    J Comput Aided Mol Des; 2015 Jun; 29(6):485-509. PubMed ID: 25940276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
    Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
    J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
    Karthik MV; Satya Deepak MV; Shukla P
    Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme.
    Leopoldini M; Malaj N; Toscano M; Sindona G; Russo N
    J Agric Food Chem; 2010 Oct; 58(19):10768-73. PubMed ID: 20843083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase.
    Medina-Franco JL; López-Vallejo F; Rodríguez-Morales S; Castillo R; Chamorro G; Tamariz J
    Bioorg Med Chem Lett; 2005 Feb; 15(4):989-94. PubMed ID: 15686898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme A reductase for cancer treatment.
    Chen JB; Chern TR; Wei TT; Chen CC; Lin JH; Fang JM
    J Med Chem; 2013 May; 56(9):3645-55. PubMed ID: 23570542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of synthesis, biological assay, and QSAR studies of HMGR inhibitors.
    García I; Fall Y; Gómez G
    Curr Top Med Chem; 2012; 12(8):895-919. PubMed ID: 22352916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.